| Application no. and date | 14774006.2 (espacenet) (Federated) (European Patent Register), 20140310 | | Patent/reg. no. and date | DK/EP 2968351, 20180829 | | Publication date | 20160120 | | Priority no. and date | US 201313829984, 20130314 | | EP pub. no. and date |
EP 2968351 20160120 | | Effective date | | | Applicant/owner | Allergan Holdings Unlimited Company, Clonshaugh Business & Technology Park
Dublin 17, IE | | Applicant ref. no. | P66299DK01 | | Inventor | JANS, Eugeen, Maria Jozef, Turnhoutseweg 30
B-2340 Beerse, BE,
CEULEMANS, Jens, Jozef, Turnhoutseweg 30
B-2340 Beerse, BE,
COSTELLO, Tim, 300 North 3rd Street
Suite 110
Wilmington, NC 28401, US,
HEYNS, Philip, Erna H., Turnhoutseweg 30
B-2340 Beerse, BE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/4174 (2006.01) , A61K 9/20 (2006.01) | | Title | OPIOID RECEPTORMODULATOR-DOSERINGSFORMULERINGER | | Int. application no. | US2014022666 | | Int. publication no. | WO2014159245 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
